CEFTAVAG TZ 1.125 INJ

CEFTAVAG TZ 1.125 Injection combines Ceftazidime 1 gram (a third-generation cephalosporin antibiotic) with Tazobactam 125 mg (a beta-lactamase inhibitor) to combat a broad range of bacterial infections, including those caused by beta-lactamase producing resistant bacteria. This combination enhances the efficacy of ceftazidime by protecting it from enzymatic degradation.

Key Features:

• Composition: Ceftazidime 1 gm + Tazobactam 125 mg

• Broad-spectrum antibacterial activity against Gram-negative and some Gram-positive bacteria

• Effective against multidrug-resistant and beta-lactamase producing pathogens

• Suitable for intravenous (IV) or intramuscular (IM) administration

Indications:

• Complicated urinary tract infections (UTIs)

• Lower respiratory tract infections including hospital-acquired pneumonia

• Intra-abdominal infections

• Skin and soft tissue infections

• Septicemia and bloodstream infections

• Bone and joint infections